These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 25745970)

  • 1. [Light chain escape followed by leukemic transformation in a patient with IgD myeloma].
    Hatsuse M; Fuchida S; Okano A; Murakami S; Shimazaki C
    Rinsho Ketsueki; 2015 Jan; 56(1):48-50. PubMed ID: 25745970
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessing the efficiency of free light chain assay in monitoring patients with multiple myeloma before and after autologous stem cell transplantation along with serum protein electrophoresis and serum protein immunofixation.
    Dogaru M; Lazăr V; Coriu D
    Roum Arch Microbiol Immunol; 2011; 70(1):15-22. PubMed ID: 21717807
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interpretation Difficulties of Serum Immunofixation Test in Immunoglobulin D Multiple Myeloma with Hidden Lambda Light Chains.
    Biaz A; Uwingabiye J; Rachid A; Dami A; Bouhsain S; Ouzzif Z; Idrissi SEM
    Clin Lab; 2018 Jun; 64(6):1065-1069. PubMed ID: 29945318
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Autologous stem cell transplantation in multiple myeloma: improved survival in nonsecretory multiple myeloma but lack of influence of age, status at transplant, previous treatment and conditioning regimen. A single-centre experience in 127 patients.
    Terpos E; Apperley JF; Samson D; Giles C; Crawley C; Kanfer E; Olavarria E; Goldman JM; Rahemtulla A
    Bone Marrow Transplant; 2003 Feb; 31(3):163-70. PubMed ID: 12621476
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A case of IgD myeloma representing a missed biclonal paraproteinemia or isotype switch in a patient previously diagnosed with IgA-lambda myeloma.
    Chepovetsky J; Chari A; Jagannath S; Ramanthan L
    Clin Chim Acta; 2013 Oct; 425():233-5. PubMed ID: 23954772
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Serum free light-chain assay for nonsecretory multiple myeloma with light chain cast nephropathy and light chain deposition disease].
    Honma R; Fukase S; Suzuki M; Omoto E
    Rinsho Ketsueki; 2010 Apr; 51(4):270-4. PubMed ID: 20467224
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Kidney failure as an unusual initial presentation of biclonal gammopathy (IgD multiple myeloma associated with light chain disease)--a case report.
    Rabrenović V; Mijušković Z; Marjanović S; Rabrenović M; Jovanović D; Antić S; Ignjatović L; Petrović M; Pilcević D
    Vojnosanit Pregl; 2015 Feb; 72(2):196-9. PubMed ID: 25831916
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IgD paraproteinemias.
    Tichý M; Matĕja F; Urban P; Matuska M
    Neoplasma; 1993; 40(1):59-61. PubMed ID: 8350950
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The tumor kinetics of multiple myeloma following autologous stem cell transplantation as assessed by measuring serum-free light chains.
    Pratt G; Mead GP; Godfrey KR; Hu Y; Evans ND; Chappell MJ; Lovell R; Bradwell AR
    Leuk Lymphoma; 2006 Jan; 47(1):21-8. PubMed ID: 16321823
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Systemic amyloidosis associated with IgD-λ multiple myeloma].
    Nagamachi Y; Yamauchi N; Muramatsu H; Inomata H; Nozawa E; Koyama R; Ihara K; Nishisato T; Yamada H; Yano T; Kikuchi S; Hirako T; Kitaoka K; Ono K; Ihara H; Kato J
    Rinsho Ketsueki; 2011 Dec; 52(12):1888-92. PubMed ID: 22241157
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Complete remission of nephrotic syndrome and improvement of renal function in a patient with light chain deposition disease following high dose chemotherapy with transplantation of autologous haematopoietic stem cells. A case study and review of literature].
    Adam Z; Krejcí M; Pour L; Stepánková S; Cermáková Z; Voska L; Teplan V; Krivanová A; Hájek R; Mayer J
    Vnitr Lek; 2009 Nov; 55(11):1089-96. PubMed ID: 20017442
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The successful use of natural alpha-interferon single therapy in multiple myeloma of IgD (lambda)-type].
    Suzuki A; Iwase O; Ohkubo T; Nakano M; Toyama K
    Rinsho Ketsueki; 1991 Jan; 32(1):47-51. PubMed ID: 1902271
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IgD-λ multiple myeloma with excessive excretion of free light chains: a diagnostic trap in the identification of monoclonal gammopathies.
    Zahir H; Tali A; Rachidi M; Mouhib H; Daif H; Ait Ouzdi Z; Haouach K; Chabaa L
    Ann Biol Clin (Paris); 2019 Feb; 77(1):107-111. PubMed ID: 30799291
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunoglobulin D myeloma: clinical features and outcome in the era of novel agents.
    Zagouri F; Kastritis E; Symeonidis AS; Giannakoulas N; Katodritou E; Delimpasi S; Repousis P; Terpos E; Dimopoulos MA;
    Eur J Haematol; 2014 Apr; 92(4):308-12. PubMed ID: 24460646
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [IgD/kappa myeloma].
    Golenkov AK; German GP; Zlatkina AR; Chernokhvostova EV; Cheredeev AN
    Ter Arkh; 1984; 56(11):129-31. PubMed ID: 6441298
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IgD multiple myeloma--a clinical profile and outcome with chemotherapy and autologous stem cell transplantation.
    Wechalekar A; Amato D; Chen C; Keith Stewart A; Reece D
    Ann Hematol; 2005 Feb; 84(2):115-7. PubMed ID: 15503021
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A case of secondary plasma cell leukemia resistant to novel agents, in which stringent complete remission was achieved and maintained for a long period of time after VAD therapy and tandem autologous transplantation.
    Sekiguchi Y; Shimada A; Wakabayashi M; Sugimoto K; Tomita S; Izumi H; Nakamura N; Sawada T; Ohta Y; Komatsu N; Noguchi M
    Int J Clin Exp Pathol; 2014; 7(9):6313-22. PubMed ID: 25337285
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma exchange combined with bortezomib-based chemotherapy is effective for early renal recovery in a patient with IgD-λ type multiple myeloma.
    Ueda H; Kuno H; Takahashi D; Katsuma A; Kimura A; Nakashima A; Kato J; Momoki M; Ohba R; Dobashi N; Yamamoto I; Kawamura T; Miyazaki Y; Yokoo T
    CEN Case Rep; 2020 May; 9(2):165-172. PubMed ID: 31974826
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Meningeal relapse after double peripheral blood stem cell transplantation in IgD myeloma.
    Ochiai N; Shimazaki C; Okano A; Hatsuse M; Takahashi R; Hirai H; Ashihara E; Inaba T; Fujita N; Nakagawa M
    Leuk Lymphoma; 2002 Mar; 43(3):641-3. PubMed ID: 12002772
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Unusual myelomas: a review of IgD and IgE variants.
    Pandey S; Kyle RA
    Oncology (Williston Park); 2013 Aug; 27(8):798-803. PubMed ID: 24133829
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.